ArticleCancers2023

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Fabien Muselli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.